Yu Yao

Also affiliated with Fudan University, Ningbo No. 2 Hospital, First Affiliated Hospital of Xi'an Jiaotong University, Ningbo University Affiliated Hospital, Shanghai Clinical Research Center, Huashan Hospital, Shanghai Center for Brain Science and Brain-Inspired Technology

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant diffuse gliomas.”.

Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant diffuse gliomas.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2506

N/A

0DataRank · unranked

4 citations

Yu Yao, Javier Villanueva‐Meyer, Matthew Grimmer, Stephanie Hilz, David Solomon +15 more

Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas

Neuro-Oncology(2021)10.1093/neuonc/noab081

N/A

0DataRank · unranked

122 citations

Javier Villanueva‐Meyer, Matthew Grimmer, Stephanie Hilz, David A. Solomon, Serah Choi +17 more